Stockscreener 앱 받기
4.81
7.14%
-0.37
시간 외 거래:
4.75
-0.06
-1.25%
전일 마감가:
$5.18
열려 있는:
$5.23
하루 거래량:
105.63K
Relative Volume:
1.39
시가총액:
$125.12M
수익:
$40,000
순이익/손실:
$-38.64M
주가수익비율:
-2.6121
EPS:
-1.8414
순현금흐름:
$-22.21M
1주 성능:
+5.71%
1개월 성능:
-12.55%
6개월 성능:
-38.57%
1년 성능:
-9.25%
1일 변동 폭
$4.80
$5.335
1주일 범위
$4.30
$5.6646
52주 변동 폭
$3.20
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
4.81 | 117.32M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates - TMX Newsfile
NTHI Q1 2026 Earnings: Wider-than-Expected EPS Loss Amid Pre-Revenue Phase; Stock Rises 5.56%Strong Earnings Momentum - newsline.com
NeOnc Technologies Announces New Series A Preferred Financing - TipRanks
NeOnc Technologies Announces Up To $5 Million Series A Convertible Preferred Private Placement - TradingView
NeOnc Technologies sets up $5M Series A preferred sale | NTHI 8-K Filing - Stock Titan
NeOnc (NTHI) virtual shareholder meeting Aug 14, 2026 — director elections, Plan Amendment - Stock Titan
NTHI Q1 2026 Earnings: EPS Misses as Clinical-Stage Biotech Reports Continued R&D Spend, Stock RisesPositive Surprise Momentum - lwvtexas.org
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade - Nasdaq
NeOnc Technologies Initiated at Buy by Alliance Global Partners - Moomoo
NTHI Q1 2026 Earnings: Wider-than-Expected Loss Reflecting Pre-Revenue R&D StageEarnings Season Preview - newsline.com
NTHI Q1 2026 Earnings: EPS Miss Reflects Pre‑Revenue Biotech’s Rising R&D BurnNegative Surprise Momentum - newsline.com
NeOnc Shares Move Up With Key Brain Cancer Trial Updates Ahead - Bez Kabli
NeonC technologies (NTHI) president buys $153k in stock - Investing.com
NTHI Q1 2026 Earnings: Clinical-Stage Biotech Misses EPS Estimates but Stock Edges HigherConsensus Forecast Report - newsline.com
NeOnc Technologies Emerges as Top Penny Stock After Analysts Issue Buy Ratings - asatunews.co.id
Alliance Global and Maxim Initiate Coverage on NeOnc Technologies - HarianBasis.co
NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy - Insider Monkey
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Continues R&D InvestmentFinal Results - The Legal Advocate
The Next Great AI Revolution May Be Drug Delivery - GlobeNewswire
Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA) - The Globe and Mail
NTHI - Finviz
BTIG Maintains NeOnc Technologies(NTHI.US) With Buy Rating, Maintains Target Price $15 - Moomoo
NeOnc Technologies (NTHI) Slips Nearly 2% as Stock Holds Above Key SupportJurik MA - The Legal Advocate
NeOnc Technologies (NTHI) Edges Lower but Holds Above Key Support as Trading Volume Remains SubduedZero Lag EMA - The Legal Advocate
NeOnc Technologies Holds Ground Near Key Support Amid Biotech Uncertainty (NTHI)Bull Flag - The Legal Advocate
NeOnc Technologies Holdings (NTHI) Holds Near Support as Modest Decline Tests Key LevelFactor Valuation - Newser
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Focuses on Pipeline Development - newsline.com
NTHI Initiated Coverage by Alliance Global Partners -- Rating Se - GuruFocus
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones - The Manila Times
NeOnc Technologies Gains Analyst Favor with Growing Insider and Institutional Interest in CNS Cancer Therapies - Quiver Quantitative
Wall Street firms back brain-cancer biotech as trial data nears - Stock Titan
A. G. P. Initiates NeOnc Technologies(NTHI.US) With Buy Rating, Announces Target Price $13 - Moomoo
NeOnc Technologies Reports Q1 2026 Results: Advancing Phase 2 CNS Cancer Trials and Strengthening Financial Position 1 2 3 - Minichart
NeOnc Provides Business Update and Reports Q1 2026 Financial Results - Sahm
NeOnc Advances Glioma Programs and Strengthens Financial Position - TipRanks
NeOnc Technologies Price Target Announced at $20.00/Share by Maxim Group - Moomoo
NeOnc Technologies (Nasdaq: NTHI) posts Q1 loss, advances NEO212 and NEO100 - Stock Titan
NeOnc Technologies Holdings, Inc. Reports Q1 2026 Financial Results and Advances Key CNS Cancer Clinical Programs - Quiver Quantitative
Cinctive Capital (NTHI) reports 2.48M shares, including 1.06M warrants - Stock Titan
NEONC TECHNOLOGIES HOLDINGS, INC. 1Q 2026: Revenue $0 EPS $(0.38) — 10-Q Summary - TradingView
NeOnc Technologies (NASDAQ: NTHI) burns cash, flags going-concern risk despite $13.1M PIPE - Stock Titan
NeOnc Technologies Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
NeOnc Technologies Holdings, Inc.Common Stock (NQ: NTHI - The Chronicle-Journal
Number of shareholders of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Neonc Technologies : NTHI - 24/7 Wall St.
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6 - Yahoo Finance
NeOnc Technologies (NASDAQ:NTHI) Positioned for Potential Breakthrough in Brain Cancer Treatment Amidst Biotech Market Shift - Quiver Quantitative
A biotech CEO spent $500K+ as a brain cancer trial nears data - Stock Titan
Biotech’s Next Wave May Already be in Motion - marketscreener.com
The quiet strength in NeOnc (NTHI) business model (Surges Ahead) 2026-05-06Day Trade - newser.com
Neonc Technologies Holdings Inc (NTHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neonc Technologies Holdings Inc 주식 (NTHI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Apr 28 '26 |
Buy |
4.52 |
10,000 |
45,180 |
3,062,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Apr 23 '26 |
Buy |
4.88 |
500 |
2,440 |
134,760 |
| Heshmatpour Amir F | President |
Apr 23 '26 |
Buy |
4.90 |
10,000 |
49,000 |
3,052,000 |
| SUH, DAVID JR. | Chief Accounting Officer |
Apr 09 '26 |
Buy |
5.00 |
200 |
1,000 |
111,866 |
| Heshmatpour Amir F | President |
Apr 10 '26 |
Buy |
4.89 |
10,000 |
48,950 |
3,042,000 |
| Heshmatpour Amir F | President |
Apr 08 '26 |
Buy |
5.61 |
10,000 |
56,050 |
3,027,000 |
| Heshmatpour Amir F | President |
Apr 09 '26 |
Buy |
5.19 |
5,000 |
25,950 |
3,032,000 |
| Heshmatpour Amir F | President |
Apr 02 '26 |
Buy |
6.09 |
20,000 |
121,798 |
3,012,000 |
| Heshmatpour Amir F | President |
Apr 06 '26 |
Buy |
6.32 |
5,000 |
31,600 |
3,017,000 |
| Heshmatpour Amir F | President |
Nov 21 '25 |
Buy |
6.07 |
24,000 |
145,600 |
2,986,000 |
2.60%
0.94%
자본화:
|
볼륨(24시간):